Hauck & Aufhaeuser Reiterates €69.00 Price Target for Carl Zeiss Meditec (AFX)

Carl Zeiss Meditec (ETR:AFX) has been given a €69.00 ($80.23) target price by equities research analysts at Hauck & Aufhaeuser in a note issued to investors on Friday. The brokerage currently has a “neutral” rating on the stock. Hauck & Aufhaeuser’s price objective suggests a potential upside of 4.39% from the company’s previous close.

Several other research analysts have also recently commented on AFX. Independent Research set a €73.00 ($84.88) target price on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Monday, August 13th. Deutsche Bank set a €65.00 ($75.58) target price on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Tuesday, August 14th. Kepler Capital Markets set a €62.00 ($72.09) target price on shares of Carl Zeiss Meditec and gave the stock a “sell” rating in a report on Monday, August 27th. Nord/LB set a €62.00 ($72.09) target price on shares of Carl Zeiss Meditec and gave the stock a “sell” rating in a report on Tuesday, September 4th. Finally, HSBC set a €75.00 ($87.21) target price on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Thursday, September 6th. Three investment analysts have rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of €65.88 ($76.60).

Shares of AFX opened at €66.10 ($76.86) on Friday. Carl Zeiss Meditec has a one year low of €37.53 ($43.64) and a one year high of €55.25 ($64.24).

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Featured Article: Technical Analysis

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply